About Index Trending news
Analyze
Top 50 Pricing
Trevena

Trevena

Work at Trevena? Add yourself to this profile

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.

Elsewhere

Alexa global traffic share

Twitter followers

05 Nov 2014
$45,000,000
Post-IPO equity
09 May 2013
$60,000,000
Venture capital (Series C)
14 Jul 2010
$35,000,000
Venture capital (Series B)
Polaris Partners, Alta Partners, HealthCare Ventures, +1
01 Mar 2008
$24,000,000
Venture capital (Series A)
Polaris Partners, Alta Partners, HealthCare Ventures, +1